Linda Overholser, MD, MPH

home / authors / linda-overholser-md-mph

Articles

Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies

Linda Overholser, MD, MPH;Elena Shagisultanova, MD, PhD;Rachel Rabinovitch, MD;Nicole Kounalakis, MD;Jennifer Diamond, MD;Christina A. Finlayson, MD;Christine M. Fisher, MD, MPH;Peter Kabos, MD;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc;Jose Mayordomo, MD, PhD

December 15th 2016

We review available strategies for screening and risk reduction through chemoprevention or risk-reducing surgery, as well as challenges for management of breast cancer in patients with prior exposure to radiation for Hodgkin lymphoma.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.

Published: August 9th 2024 | Updated: August 14th 2024

Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets

Published: June 2nd 2024 | Updated: June 3rd 2024

OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer

Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.

Published: May 6th 2024 | Updated: May 21st 2024

FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications

Published: April 15th 2022 | Updated: September 13th 2024

Metastatic Renal Cell Carcinoma With Sarcomatoid Features

Published: August 20th 2014 | Updated: September 13th 2024

A 60-Year-Old Man Presents With Plantar Hyperkeratosis & Erythema

Published: July 7th 2016 | Updated: September 13th 2024

Subpleural Mass in 46-Year-Old Patient

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777